Skip to content

THT wants votes for Labour's policy-making website by Friday 13th October

Continuing 3TC therapy after viral rebound shows no benefit

Lab markers can predict advanced liver fibrosis in more than 90% of cases in HIV/HCV coinfected

Two-drug maintenance with tenofovir-efavirenz less effective than triple therapy

Hepatitis C infection limits cholesterol increases caused by antiretrovirals

Darunavir response did not differ by prior PI in POWER studies

Reduced dose of Kaletra soft-gel capsule effective in small study (corrected)

Immunologically discordant response to HIV therapy associated with increased risk of disease progression

Needle-free administration of enfuvirtide reduces injection site reactions